Pharmaceutical Intermediates Market Size, Share, Analysis, Trends, Growth, 2032

Pharmaceutical Intermediates Market Insights

Zion Market Research has published a report on the global Pharmaceutical Intermediates Market, estimating its value at USD 40.22 Billion in 2023, with projections indicating that it will reach USD 59.25 Billion by 2032. The market is expected to expand at a compound annual growth rate (CAGR) of 4.4% over the forecast period 2024-2032. The report explores the factors fueling market growth, the hitches that could hamper this expansion, and the opportunities that may arise in the Pharmaceutical Intermediates Market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.

Request Free Sample

The report offers assessment and analysis of the Pharmaceutical Intermediates Market on a globaland regional level. The study offers a comprehensive assessment ofthe market competition, constraints, revenue estimates,opportunities, evolving trends, and industry-validated data. Thereport provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Million).

Pharmaceutical Intermediates Market: Overview

Pharmaceutical Intermediates are utilized as raw componentsduring bulk drug production. Moreover, they are chemical compoundsthat form building blocks of active pharmaceutical ingredient (API). These products are produced as by-products while producing API. Nonetheless, bio-pharma and pharma firms are focusing onimproving their product reach in various countries across globe.These firms are trying to increase production capacities indifferent parts of globe.

Request Free Sample

Pharmaceutical Intermediates Market: Growth Drivers

Rise in occurrence of chronic disorders such as diabetes, heartailments, and kidney-related problems will drive market trends. Asper WHO, persons above sixty years of age is projected to surpass 2billion by 2050. Reportedly, WHO has also claimed diabetes to bemajor cause of heart attack, kidney failure, and stoke. In additionto this, prominently surging geriatric population will embellishgrowth of Pharmaceutical Intermediates Market over anticipated timeline. Apparently, use of new technologies including highthroughput, combinatorial chemistry, and bio-informatics will propup expansion of Pharmaceutical Intermediates industry over forecast timespan. Growing reach of various pharma players in emergingeconomies will pave way for expansion of Pharmaceutical Intermediates market over assessment timeline.

Pharmaceutical Intermediates Market: Report Scope

Furthermore, wide use of Pharmaceutical Intermediates Market indomain of clinical research will prompt business expansion inupcoming years. In addition to this, outbreak of COVID-19 pandemichas encouraged players in biotech and pharmaceutical sectors tofocus on drug production activities, thereby enlarging scope of Pharmaceutical Intermediates industry over assessment period.

Pharmaceutical Intermediates Market: Regional Landscape

North America To Dominate Overall Market Growth By 2032

Expansion of Pharmaceutical Intermediates Market in North America over assessment period is due to surge in research & development activities in countries such as Canada and the U.S.Apart from this, surge in occurrence of myriad chronic conditions will further contribute towards regional market proceeds overupcoming years. For the record, heart disorder causes nearly 8 lacdeaths in the U.S.

Pharmaceutical Intermediates Market: Competitive Landscape

Key participants leveraging growth of PharmaceuticalIntermediates Market and profiled in study include

• Codexis Inc.
• Midas Pharma GmbH
• Cycle Pharma
• Dextra Laboratories Ltd.
• BASF SE,Chemcon Specialty Chemicals Pvt. Ltd
• A.R. Life Sciences PrivateLimited
• Dishman Group
• Sanofi Winthrop Industrie S.A.
• ZCLChemicals Ltd.
• Vertellus Holdings LLC
• Aceto Corporation,Lianhetech
• Easter Chemical Corporation.      

The global Pharmaceutical Intermediates Market is segmented asfollows:

By Application

• Antibiotics
• Vitamins
• Antipyretic Analgesics

By Distribution Channel

• Direct Sales
• Distributor

By Product Type

• GMP
• Non-GMP

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa